OVERVIEW

We invite you to join us for the 5th Annual Best of Breast conference. This innovative and state of the art program is set completely in a multidisciplinary tumor board environment with some of the world's leading breast cancer experts to discuss cases beginning with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care, and survivorship and recurrence—all while incorporating data from the major oncologic annual meetings. 

The program will be followed by a product showcase segment, promoting personalized time between thought-leaders and commercial medical experts and concluded with an invitation-only publication round-table with KOLS developing clinical consensus statements.

LEARNING OBJECTIVES

• Discuss strategies for at-risk screening and prevention in breast cancer.
• Discuss advances in diagnostic testing including screening, genomic assays for therapeutic decision making in early breast cancer, ctDNA and MRD, and comprehensive genomic profiling.
• Discuss applications in therapeutic strategies for adjuvant disease.
• Discuss applications in therapeutic strategies for metastatic disease.
• Discuss patient and advocacy issues in breast cancer like adherence and compliance to therapy, managing side effects, and developing plans for life after cancer.

ACCREDITATION

Amedco LLC designates this live activity for a maximum of TBD AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For more information please visit the official event page.